Kohane DS - Search Results

1

Rwei AY, Paris JL, Wang B, Wang W, Axon CD, Vallet-Regí M, Langer R, Kohane DS. Rwei AY, et al. Among authors: kohane ds. Nat Biomed Eng. 2017;1:644-653. doi: 10.1038/s41551-017-0117-6. Epub 2017 Aug 9. Nat Biomed Eng. 2017. PMID: 29152410 Free PMC article.

2

A re-examination of tetrodotoxin for prolonged duration local anesthesia.

Kohane DS, Yieh J, Lu NT, Langer R, Strichartz GR, Berde CB. Kohane DS, et al. Anesthesiology. 1998 Jul;89(1):119-31. doi: 10.1097/00000542-199807000-00019. Anesthesiology. 1998. PMID: 9667302 Free article.

3

Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers.

Kohane DS, Kuang Y, Lu NT, Langer R, Strichartz GR, Berde CB. Kohane DS, et al. Anesthesiology. 1999 Feb;90(2):524-34. doi: 10.1097/00000542-199902000-00029. Anesthesiology. 1999. PMID: 9952161 Free article.

4

Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine.

Kohane DS, Lipp M, Kinney RC, Lotan N, Langer R. Kohane DS, et al. Pharm Res. 2000 Oct;17(10):1243-9. doi: 10.1023/a:1026470831256. Pharm Res. 2000. PMID: 11145230

5

Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.

Kohane DS, Lipp M, Kinney RC, Anthony DC, Louis DN, Lotan N, Langer R. Kohane DS, et al. J Biomed Mater Res. 2002 Mar 5;59(3):450-9. doi: 10.1002/jbm.1261. J Biomed Mater Res. 2002. PMID: 11774302

6

Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility.

Kohane DS, Plesnila N, Thomas SS, Le D, Langer R, Moskowitz MA. Kohane DS, et al. Brain Res. 2002 Aug 16;946(2):206-13. doi: 10.1016/s0006-8993(02)02878-0. Brain Res. 2002. PMID: 12137923

7

Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres.

Kohane DS, Smith SE, Louis DN, Colombo G, Ghoroghchian P, Hunfeld NG, Berde CB, Langer R. Kohane DS, et al. Pain. 2003 Jul;104(1-2):415-21. doi: 10.1016/s0304-3959(03)00049-6. Pain. 2003. PMID: 12855352

8

pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles.

Kohane DS, Anderson DG, Yu C, Langer R. Kohane DS, et al. Pharm Res. 2003 Oct;20(10):1533-8. doi: 10.1023/a:1026162628965. Pharm Res. 2003. PMID: 14620503

9

Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve.

Colombo G, Langer R, Kohane DS. Colombo G, et al. Among authors: kohane ds. J Biomed Mater Res A. 2004 Mar 15;68(4):651-9. doi: 10.1002/jbm.a.20074. J Biomed Mater Res A. 2004. PMID: 14986320

10

Microparticulate formulations for the controlled release of interleukin-2.

Thomas TT, Kohane DS, Wang A, Langer R. Thomas TT, et al. Among authors: kohane ds. J Pharm Sci. 2004 May;93(5):1100-9. doi: 10.1002/jps.20009. J Pharm Sci. 2004. PMID: 15067687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters